Skip to main content


NextGen Cancer Science Seminar - April 15, 2021


More information and a recording of the talk is available below.

For questions about this event, please reach out to Mary Christie at

The Evolving Role of Precision Medicine in Lung Cancer


Headshot of Dr. Richard Hammer

Presented by Dr. Richard Hammer, Vice-Chair of Clinical Affairs, Dept of Pathology & Anatomical Sciences, and Kali Dougherty MS, CGC (Foundation Medicine)

The seminar:
Outlines the clinical implications of tumor testing strategies for patients with lung cancer, including comprehensive genomic profiling, hotspot analysis, tissue and liquid biopsies
•    Identifies the role of multidisciplinary teams in facilitation and implementation of molecular testing in oncology care settings
•    Assesses methods to overcome barriers to personalized medicine and increase molecular testing, tumor boards, and clinical trial referral in the community setting
•    Applies available molecular testing to develop evidence-based individualized treatment decisions for cancer patients
•    Reviews recent advancements in comprehensive genomic profiling for advanced lung cancer
•    Discusses potential applications of liquid biopsy for patients with advanced lung cancer and review available resources for physicians utilizing comprehensive genomic profiling